Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients

Abroad (travel likely)Recruiting

Conditions

Aniridia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hôpital Fondation A. de Rothschild, Paris, France
Contact: Study coordinator (Damien GUINDOLET) · dguindolet@for.paris
Contact: Study coordinator (Eric GABISON) · egabison@for.paris

Study leads

Eric GABISON
Study Chair
Hôpital Fondation A. de Rothschild
Damien GUINDOLET
Principal Investigator
Hôpital Fondation A. de Rothschild

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

National Cohort on Congenital Defects of the Eye

Anophthalmia · Microphthalmia · Aniridia

Abroad (travel likely)Recruiting

Paris, France

National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

Inherited Ophthalmic Diseases · Hypopigmentation Disorder · Corneal Dystrophy

Abroad (travel likely)Recruiting

Bethesda, United States · Bethesda, United States

Congenital Aniridia Patient Questionnaire

Congenital Aniridia

Abroad (travel likely)Recruiting

Paris, France

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Rare Disorders · Undiagnosed Disorders · Disorders of Unknown Prevalence

Abroad (travel likely)Recruiting

Sioux Falls, United States · Sydney, Australia